E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
The framework builds on WHO’s Greener pharmaceuticals’ regulatory highway call to action, launched in 2024.
imphoenix82
In eastern Africa, WHO now recommends combining the oral medicine miltefosine with paromomycin injections for treating both kala-azar and post-kala-azar dermal leishmaniasis (PKDL) . In South-East Asia, new combination therapies using liposomal amphotericin B, either alone or together with miltefosine, are recommended for PKDL.
imphoenix82
Ahead of World Drowning Prevention Day, WHO launches the PROTECT package, providing countries with practical, evidence-based approaches to reduce drowning deaths, including making water transport safer, teaching school kids to swim, and preparing for floods.
imphoenix82
WHO calls for placing people affected by cancer at the centre of cancer control efforts
imphoenix82
World Health Assembly Global Parliamentary Forum underscores the critical role of parliaments in translating global commitments into concrete action.
imphoenix82
The newly listed test detects Bundibugyo virus by identifying its genetic material in blood samples, enabling rapid and accurate confirmation of infection.
imphoenix82
Patients and healthcare providers are advised not to use any DARZALEX products bearing batch numbers MYS7381 or STV1K01.
imphoenix82
WHO is encouraging all countries to begin newborn screening with priority conditions and gradually expand as healthcare capacity grows.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
